Eam Global Investors LLC Cassava Sciences Inc Transaction History

Eam Global Investors LLC

  • $435 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$41.79 - $135.3 $1.32 Million - $4.28 Million
-31,644 Closed
0 $0
Q2 2021

Aug 13, 2021
SELL
$32.15 - $89.72 $246,172 - $686,986
-7,657 Reduced 19.48%
31,644 $2.7 Million
Q1 2021

May 11, 2021
BUY
$7.09 - $87.95 $278,644 - $3.46 Million
39,301 New
39,301 $1.77 Million

Others Institutions Holding SAVA

# of Institutions
201
Shares Held
13.9M
Call Options Held
2.98M
Put Options Held
6.57M
View Full List

About CASSAVA SCIENCES INC

SAVA Quotes by TradingView
  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $108M
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Eam Global Investors LLC Portfolio

Follow Eam Global Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Global Investors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email